• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KRIT1:氧化还原信号与脑动静脉畸形病发病机制之间的繁忙十字路口的交通管理员。

KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease.

机构信息

Department of Clinical and Biological Sciences, University of Torino, Torino, Italy.

CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, Torino, Italy.

出版信息

Antioxid Redox Signal. 2023 Mar;38(7-9):496-528. doi: 10.1089/ars.2021.0263. Epub 2022 Nov 1.

DOI:10.1089/ars.2021.0263
PMID:36047808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10039281/
Abstract

KRIT1 (Krev interaction trapped 1) is a scaffolding protein that plays a critical role in vascular morphogenesis and homeostasis. Its loss-of-function has been unequivocally associated with the pathogenesis of Cerebral Cavernous Malformation (CCM), a major cerebrovascular disease of genetic origin characterized by defective endothelial cell-cell adhesion and ensuing structural alterations and hyperpermeability in brain capillaries. KRIT1 contributes to the maintenance of endothelial barrier function by stabilizing the integrity of adherens junctions and inhibiting the formation of actin stress fibers. Among the multiple regulatory mechanisms proposed so far, significant evidence accumulated over the past decade has clearly shown that the role of KRIT1 in the stability of endothelial barriers, including the blood-brain barrier, is largely based on its involvement in the complex machinery governing cellular redox homeostasis and responses to oxidative stress and inflammation. KRIT1 loss-of-function has, indeed, been demonstrated to cause an impairment of major redox-sensitive mechanisms involved in spatiotemporal regulation of cell adhesion and signaling, which ultimately leads to decreased cell-cell junction stability and enhanced sensitivity to oxidative stress and inflammation. This review explores the redox mechanisms that influence endothelial cell adhesion and barrier function, focusing on the role of KRIT1 in such mechanisms. We propose that this supports a novel model wherein redox signaling forms the common link between the various pathogenetic mechanisms and therapeutic approaches hitherto associated with CCM disease. A comprehensive characterization of the role of KRIT1 in redox control of endothelial barrier physiology and defense against oxy-inflammatory insults will provide valuable insights into the development of precision medicine strategies. 38, 496-528.

摘要

KRIT1(Krev 相互作用陷 1)是一种支架蛋白,在血管形态发生和稳态中起着关键作用。其功能丧失与脑动静脉畸形(CCM)的发病机制明确相关,CCM 是一种主要的遗传性脑血管疾病,其特征是内皮细胞-细胞黏附缺陷,并随后导致脑毛细血管的结构改变和通透性增加。KRIT1 通过稳定黏附连接的完整性并抑制肌动蛋白应力纤维的形成,有助于维持内皮屏障功能。到目前为止,已经提出了多种调节机制,过去十年积累的大量证据清楚地表明,KRIT1 在维持内皮屏障(包括血脑屏障)的稳定性中的作用主要基于其参与调节细胞氧化还原稳态以及对氧化应激和炎症反应的复杂机制。KRIT1 功能丧失确实导致涉及细胞黏附和信号时空调节的主要氧化还原敏感机制受损,最终导致细胞-细胞连接稳定性降低和对氧化应激和炎症的敏感性增强。本综述探讨了影响内皮细胞黏附和屏障功能的氧化还原机制,重点介绍了 KRIT1 在这些机制中的作用。我们提出,这支持了一种新的模型,其中氧化还原信号是各种发病机制和迄今为止与 CCM 疾病相关的治疗方法之间的共同联系。全面描述 KRIT1 在氧化还原控制内皮屏障生理学和抵御氧炎性损伤中的作用,将为开发精准医学策略提供有价值的见解。Cell 38, 496-528.

相似文献

1
KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease.KRIT1:氧化还原信号与脑动静脉畸形病发病机制之间的繁忙十字路口的交通管理员。
Antioxid Redox Signal. 2023 Mar;38(7-9):496-528. doi: 10.1089/ars.2021.0263. Epub 2022 Nov 1.
2
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease.KRIT1 功能丧失会导致慢性 Nrf2 介导的适应性稳态,使细胞对氧化应激敏感:对脑静脉畸形病的影响。
Free Radic Biol Med. 2018 Feb 1;115:202-218. doi: 10.1016/j.freeradbiomed.2017.11.014. Epub 2017 Nov 21.
3
Production of KRIT1-knockout and KRIT1-knockin Mouse Embryonic Fibroblasts as Cellular Models of CCM Disease.KRIT1 敲除和 KRIT1 敲入鼠胚胎成纤维细胞的制备及其作为 CCM 疾病细胞模型的应用。
Methods Mol Biol. 2020;2152:151-167. doi: 10.1007/978-1-0716-0640-7_12.
4
From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease.从基因与机制到分子靶向治疗:治愈脑海绵状血管畸形(CCM)疾病的漫长征程。
Methods Mol Biol. 2020;2152:3-25. doi: 10.1007/978-1-0716-0640-7_1.
5
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction.KRIT1 缺乏促进主动脉内皮功能障碍。
Int J Mol Sci. 2019 Oct 5;20(19):4930. doi: 10.3390/ijms20194930.
6
KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun.KRIT1 功能丧失导致 ROS 依赖性的 c-Jun 上调。
Free Radic Biol Med. 2014 Mar;68(100):134-47. doi: 10.1016/j.freeradbiomed.2013.11.020. Epub 2013 Nov 28.
7
Defective autophagy is a key feature of cerebral cavernous malformations.自噬缺陷是脑海绵状血管畸形的一个关键特征。
EMBO Mol Med. 2015 Nov;7(11):1403-17. doi: 10.15252/emmm.201505316.
8
KRIT1 in vascular biology and beyond.KRIT1 在血管生物学及其他领域的作用。
Biosci Rep. 2024 Jul 31;44(7). doi: 10.1042/BSR20231675.
9
Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin.脑动静脉畸形发病机制中的氧化应激和炎症:同一问题的两个方面。
Int J Biochem Cell Biol. 2016 Dec;81(Pt B):254-270. doi: 10.1016/j.biocel.2016.09.011. Epub 2016 Sep 14.
10
KRIT1 loss-mediated upregulation of NOX1 in stromal cells promotes paracrine pro-angiogenic responses.KRIT1 缺失介导的基质细胞中 NOX1 的上调促进旁分泌促血管生成反应。
Cell Signal. 2020 Apr;68:109527. doi: 10.1016/j.cellsig.2020.109527. Epub 2020 Jan 7.

引用本文的文献

1
A Systematic Review of MicroRNAs in Hemorrhagic Neurovascular Disease: Cerebral Cavernous Malformations as a Paradigm.出血性神经血管疾病中微小RNA的系统评价:以脑海绵状血管畸形为例
Int J Mol Sci. 2025 Apr 17;26(8):3794. doi: 10.3390/ijms26083794.
2
Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment.凝集素型氧化低密度脂蛋白受体-1作为脑海绵状血管畸形治疗的潜在靶点。
Front Neurosci. 2024 Aug 21;18:1442110. doi: 10.3389/fnins.2024.1442110. eCollection 2024.
3
Transcriptomic signatures of individual cell types in cerebral cavernous malformation.脑动静脉畸形中单个细胞类型的转录组特征。
Cell Commun Signal. 2024 Jan 9;22(1):23. doi: 10.1186/s12964-023-01301-2.
4
Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease.鉴定半乳糖凝集素-3作为脑海绵状血管畸形疾病一种新型潜在的预后/预测生物标志物和治疗靶点。
Genes Dis. 2023 Apr 3;11(1):67-71. doi: 10.1016/j.gendis.2023.02.045. eCollection 2024 Jan.
5
Impaired retinoic acid signaling in cerebral cavernous malformations.脑动静脉畸形中视黄酸信号转导受损。
Sci Rep. 2023 Apr 5;13(1):5572. doi: 10.1038/s41598-023-31905-0.
6
Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease.用于海绵状脑畸形疾病联合治疗的多药负载脂质纳米乳剂
Biomedicines. 2023 Feb 7;11(2):480. doi: 10.3390/biomedicines11020480.
7
Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events.发育性静脉异常附近的脑海绵状血管畸形的远处复发:局部氧化炎症事件的病例报告。
Int J Mol Sci. 2022 Nov 24;23(23):14643. doi: 10.3390/ijms232314643.
8
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress.小鼠 KRIT1 杂合缺失影响肝脏的代谢功能,促进肝氧化应激和糖基化应激。
Int J Mol Sci. 2022 Sep 22;23(19):11151. doi: 10.3390/ijms231911151.

本文引用的文献

1
Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM).下一代测序技术推动了脑海绵状血管畸形(CCM)的基因诊断。
Antioxidants (Basel). 2022 Jun 29;11(7):1294. doi: 10.3390/antiox11071294.
2
Notch3 regulates ferroptosis via ROS-induced lipid peroxidation in NSCLC cells.Notch3 通过 ROS 诱导的脂质过氧化调节 NSCLC 细胞中的铁死亡。
FEBS Open Bio. 2022 Jun;12(6):1197-1205. doi: 10.1002/2211-5463.13393. Epub 2022 Mar 18.
3
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology.定义特定活性氧(ROS)在细胞生物学和生理学中的作用。
Nat Rev Mol Cell Biol. 2022 Jul;23(7):499-515. doi: 10.1038/s41580-022-00456-z. Epub 2022 Feb 21.
4
GCKIII (Germinal Center Kinase III) Kinases STK24 and STK25 (Serine/Threonine Kinase 24 and 25) Inhibit Cavernoma Development.GCKIII(生发中心激酶 III)激酶 STK24 和 STK25(丝氨酸/苏氨酸激酶 24 和 25)抑制海绵状血管瘤的发展。
Stroke. 2022 Mar;53(3):976-986. doi: 10.1161/STROKEAHA.121.036940. Epub 2022 Feb 8.
5
The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases.自噬与氧化应激在视网膜退行性疾病发病机制及治疗中的相互作用
Cell Biosci. 2022 Jan 3;12(1):1. doi: 10.1186/s13578-021-00736-9.
6
Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies.靶向治疗缺血性脑卒中的生物活性纳米颗粒衍生的活性氧响应和炎症缓解纳米治疗。
ACS Nano. 2021 Oct 26;15(10):16076-16094. doi: 10.1021/acsnano.1c04753. Epub 2021 Oct 4.
7
Endothelial to Mesenchymal Transition: An Insight in Atherosclerosis.内皮细胞向间充质细胞转变:对动脉粥样硬化的深入了解
Front Cardiovasc Med. 2021 Sep 17;8:734550. doi: 10.3389/fcvm.2021.734550. eCollection 2021.
8
Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species.抗氧化剂通过阻断线粒体活性氧来威胁多激酶抑制剂对肝癌的疗效。
Antioxidants (Basel). 2021 Aug 24;10(9):1336. doi: 10.3390/antiox10091336.
9
The TGF-β/NADPH Oxidases Axis in the Regulation of Liver Cell Biology in Health and Disease.TGF-β/NADPH 氧化酶轴在健康和疾病中对肝细胞生物学的调控作用。
Cells. 2021 Sep 3;10(9):2312. doi: 10.3390/cells10092312.
10
The Mechanobiology of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease.心血管疾病中内皮-间充质转化的力学生物学
Front Physiol. 2021 Sep 9;12:734215. doi: 10.3389/fphys.2021.734215. eCollection 2021.